In the study, we found that a new population of CD3+C1q+TAM regulated the anti-tumor immunity of the tumor-infiltrated CD8+CCL4+T cells through the C1q signaling pathway and subsequent metabolic and epigenetic remodeling, thereby potentially affecting tumor prognosis. The gene discussed is CD8A; the disease is neoplasm.